Pharmacology, Toxicology and Pharmaceutical Science
Breast Cancer
100%
Erlotinib
100%
Meropenem
100%
Pharmacokinetic
100%
Carbon 11
75%
Blood-Brain Barrier
66%
Normal Human
55%
Genistein
50%
Actaea racemosa
50%
Polypeptide
50%
Endometrium Carcinoma
50%
Microdialysis
50%
Androgen
50%
Endometrium Cancer
50%
Cefuroxime
50%
Sulfatase
50%
Vancomycin
50%
ABCG2
50%
Daidzein
50%
Estrone Sulfate
35%
Estrogen Receptor Alpha
22%
Diethylstilbestrol
22%
Subarachnoid Hemorrhage
20%
Soybean
18%
Ciclosporin
16%
Estradiol 17 Glucuronide
16%
Intestine Enzyme
16%
Imatinib
16%
Prasterone
14%
Antibiotics
12%
Antimicrobial Therapy
12%
Brain Infection
12%
Central Nervous System Infection
12%
Digestant
12%
Detoxication
12%
CYP1B1
12%
SLCO1B3
12%
Lapatinib
11%
Protein Tyrosine Kinase Inhibitor
11%
Tariquidar
11%
Drug-Drug Interaction
10%
Tocilizumab
10%
Sulfate
9%
Hormone Precursor
9%
Drug Concentration
8%
Catechol Estrogen
8%
Cancer Growth
7%
Estrone
7%
Androstenedione
7%
Side Effect
6%
Immunology and Microbiology
Brain Tissue
100%
Blood Plasma
66%
Cerebrospinal Fluid
62%
Microdialysis
62%
Blood Level
61%
Normal Human
57%
Antimicrobial Agent
50%
Erythrocyte
50%
Antimicrobial Activity
50%
Pharmacokinetic
50%
Bacterial Growth
50%
Hypericum Perforatum Extract
50%
Minimum Inhibitory Concentration
43%
Steady State
35%
Hypericum perforatum
17%
Blood Component
16%
Escherichia coli
14%
High Performance Liquid Chromatography
14%
Bactericidal Activity
12%
Hepatobiliary System
12%
Gall Bladder
12%
Body Fluid
12%
Blood Brain Barrier
11%
Basolateral Membrane
10%
FVB Mouse
10%
Pharmacodynamics
7%
Protein Binding
7%
Pseudomonas aeruginosa
7%
Staphylococcus aureus
7%
Creatinine Clearance
7%
Glucose Brain Level
7%
Infectious Agent
6%
Plasma Protein Binding
6%
Ultrafiltration
6%
Central Nervous System
6%
MIC90
6%
Brain-to-Plasma Ratio
6%
Loading Drug Dose
6%
Effective Concentration
6%
Bacterial Strain
5%
Drug Concentration
5%
